Pharmaceuticals - DuPont seeks FDA protection of Coumadin

被引：0
作者：
不详
机构：
来源：
EUROPEAN CHEMICAL NEWS | 1997年 / 68卷 / 1792期
关键词：
D O I：
暂无
中图分类号：
TQ [化学工业];
学科分类号：
0817 ;
摘要：
引用
收藏
页码：4 / 4
页数：1
相关论文
共 50 条
[31]   Pharmaceuticals - Dupont Merck, Cytogen settle spat [J].
Westervelt, R .
CHEMICAL WEEK, 1998, 160 (21) :14-14
[32]   FDA seeks to ensure product quality [J].
Wechsler, J .
BIOPHARM INTERNATIONAL, 2005, 18 (12) :20-21
[33]   FDA seeks safer drugs and biologics [J].
Wechsler, Jill .
BIOPHARM INTERNATIONAL, 2007, 20 (03) :24-+
[34]   FDA Seeks Transparency in Data and Decisions [J].
Wechsler, Jill .
BIOPHARM INTERNATIONAL, 2010, 23 (07) :18-19
[35]   Regulation FDA seeks more flexibility [J].
Adriaanse, Chris .
CHEMISTRY & INDUSTRY, 2010, (20) :9-9
[36]   FDA seeks comments on labeling proposals [J].
Nachay, Karen .
FOOD TECHNOLOGY, 2011, 65 (05) :14-14
[37]   FDA seeks input from stakeholders [J].
Nightingale, SL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (10) :872-872
[38]   FDA SEEKS DIOXIN RISK COMMENTS [J].
GASCH, M .
PIMA MAGAZINE, 1994, 76 (08) :16-16
[39]   FDA seeks to close xenotransplant gap [J].
MacIlwain, C .
NATURE, 1997, 388 (6641) :411-411
[40]   FDA SEEKS INPUT ON FEES FOR BIOSIMILARS [J].
不详 .
CHEMICAL & ENGINEERING NEWS, 2011, 89 (20) :27-27
12345